Blood test shows promise in detecting pancreatic cancer early—a ‘holy grail’ for the field
Pancreatic cancer is typically caught in its latest stages, when it is hardest to treat
Search fresh public links, source activity, and ready-to-use post angles for Pancreatic-Cancer.
Fresh curated links around pancreatic-cancer are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Pancreatic cancer is typically caught in its latest stages, when it is hardest to treat
THURSDAY, Sept. 17, 2026 — An experimental blood test might be able to detect pancreatic cancer at its earliest stages, potentially saving countless lives, a new study says. The te...
An investigational blood test may allow for detection of pancreatic cancer at its earliest stages when it is potentially curable, according to prospective study results.The liquid...
Pancreatic cancer is considered one of the hardest to treat and most serious forms of cancer
WASHINGTON — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment agai...
Would you take a pancreatic-cancer blood test if it became available before doctors knew exactly how to interpret every positive result? Pancreatic cancer has a timing problem: It...
Learn about a new blood test that could allow physicians to detect pancreatic cancer in its earliest stages by combining multiple biomarkers.
New drug targets offer potential pathway for pancreatic cancer treatment
In a study involving 1,785 people, researchers identified a test that can help diagnose early-stage pancreatic cancer.
Blocking one gene’s activity shifted aggressive pancreatic cancer cells into a less aggressive form in experiments, pointing to a possible way to disrupt tumor evolution. Pancreati...
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
Peer-reviewed case report documents 90% volume reduction together with extensive necrosis — achieved without surgery or full-dose chemotherapy after gemcitabine failed SAN DIEGO, S...
An experimental blood test could help detect early pancreatic cancer and precancerous changes, guiding decisions about further testing. People at high risk of pancreatic cancer are...
Pancreatic cancer has long been one of medicine’s most stubborn adversaries, a disease so aggressive and so difficult to detect in its early stages that it is often described as th...
Pancreatic cancer remains one of the most formidable diagnoses in modern medicine, and a new case report is drawing attention for a strikingly inventive solution to one of its most...
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor...
Frontline researcher sees newly approved medication as ‘critical first step’ toward transformation of care. The post Has Pancreatic Cancer Met Its Match? appeared first on The Good...
A clinical trial at the University of Chicago Medicine is offering hope to patients with one of the deadliest and hardest-to-treat cancers: late-stage (metastatic) pancreatic cance...
The FDA just approved a first-of-its-kind treatment for the deadliest and most common form of pancreatic cancer — and it nearly doubled survival time in clinical trials.
This is critical for such a difficult-to-treat, deadly cancer.
A breakthrough drug recently approved to treat advanced pancreatic cancer may show promise against lung cancer as well, a new study suggests.
The Food and Drug Administration’s approval last month of a new drug for pancreatic cancer marked the end of a long quest to develop a medicine that can hit one of cancer’s most el...
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets the RAS family of proteins. Catch up on...
The Food and Drug Administration on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive for...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.